Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says

NDTV Profit 2022-02-26

Views 4

Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Laurus Labs In Focus | Ask Profit | NDTV Profit
play
00:00

Laurus Labs In Focus | Ask Profit | NDTV Profit
Talking Point With Laurus Labs' Satyanarayana Chava
play
35:10

Talking Point With Laurus Labs' Satyanarayana Chava
Laurus Labs In Focus | Profit Insight | NDTV Profit
play
00:00

Laurus Labs In Focus | Profit Insight | NDTV Profit
Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
play
26:05

Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
Laurus Labs Management On Q1 Report Card & More
play
20:29

Laurus Labs Management On Q1 Report Card & More
Ideas for Profit | Laurus Labs
play
02:48

Ideas for Profit | Laurus Labs
Laurus Labs' Growth Strategies For Q4 & Beyond
play
29:13

Laurus Labs' Growth Strategies For Q4 & Beyond
Laurus Labs In Focus | Profit Insight | NDTV Profit
play
27:06

Laurus Labs In Focus | Profit Insight | NDTV Profit
Q1 Review: Muted June Quarter For Laurus Labs
play
25:42

Q1 Review: Muted June Quarter For Laurus Labs
Analysts' View On Buzzing Stocks Like HUL, ZEEL, Laurus Labs & More On Hot Money With Darshan Mehta
play
27:52

Analysts' View On Buzzing Stocks Like HUL, ZEEL, Laurus Labs & More On Hot Money With Darshan Mehta
Laurus Labs Forays Into Biotech Segment Via Acquisition
play
12:41

Laurus Labs Forays Into Biotech Segment Via Acquisition
Q1 Review | Laurus Labs' Founder Shares Earnings Insights
play
23:30

Q1 Review | Laurus Labs' Founder Shares Earnings Insights